(Q34462060)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11741691%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

review article

1 reference

title

Native-like, long synthetic peptides as components of sub-unit vaccines: practical and theoretical considerations for their use in humans (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11741691%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11741691%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

author name string

S Demotz

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11741691%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

C Moulon

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11741691%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

M A Roggero

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11741691%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

S Masina

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11741691%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

publication date

1 December 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11741691%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11741691%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

volume

38

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11741691%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11741691%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

page(s)

415-422

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11741691%20AND%20SRC:MED&resulttype=core&format=json

Development of vaccines against human parasitic diseases: tools, current status and perspectives

4 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900077-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900077-3

1 reference

7 January 2021

The optimization of helper T lymphocyte (HTL) function in vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900077-3

7 January 2021

The role of H2-O and HLA-DO in major histocompatibility complex class II-restricted antigen processing and presentation

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900077-3

7 January 2021

Cutaneous vaccination: the skin as an immunologically active tissue and the challenge of antigen delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900077-3

7 January 2021

Applied genome research in the field of human vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900077-3

7 January 2021

Structure of the human class I histocompatibility antigen, HLA-A2

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900077-3

7 January 2021

Cytotoxic T-lymphocyte escape viral variants: how important are they in viral evasion of immune clearance in vivo?

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900077-3

7 January 2021

Human pathogen subversion of antigen presentation

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900077-3

7 January 2021

Invariant chain structure and MHC class II function

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900077-3

7 January 2021

Why do we lack an effective vaccine against herpes simplex virus infections?

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900077-3

7 January 2021

Heteroclitic immunization induces tumor immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900077-3

7 January 2021

New strategies for closing the gap of measles susceptibility in infants: towards vaccines compatible with current vaccination schedules

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900077-3

7 January 2021

Maternal immunization against viral disease

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900077-3

7 January 2021

Mutant hepatitis B viruses: a matter of academic interest only or a problem with far-reaching implications?

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900077-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900077-3

1 reference

7 January 2021

Safety and immunogenicity of intranasally administered inactivated trivalent virosome-formulated influenza vaccine containing Escherichia coli heat-labile toxin as a mucosal adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900077-3

7 January 2021

Two complementary methods for predicting peptides binding major histocompatibility complex molecules.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900077-3

7 January 2021

Adjuvants for human vaccines--current status, problems and future prospects

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900077-3

7 January 2021

HLA-DM and the MHC class II antigen presentation pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900077-3

7 January 2021

Towards clinical testing of a single-administration tetanus vaccine based on PLA/PLGA microspheres

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900077-3

7 January 2021

The role of IL-10 in promoting disease progression in leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900077-3

7 January 2021

Production of recombinant subunit vaccines: protein immunogens, live delivery systems and nucleic acid vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900077-3

7 January 2021

Chemical Synthesis of Peptides and Proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900077-3

7 January 2021

Induction of a cytotoxic T lymphocyte response by immunization with a malaria specific CTL peptide entrapped in biodegradable polymer microspheres

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900077-3

7 January 2021

T cell recognition of major histocompatibility complex class II complexes with invariant chain processing intermediates

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900077-3

7 January 2021

Challenges and opportunities for development of an AIDS vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900077-3

7 January 2021

The role of lysosomal proteinases in MHC class II-mediated antigen processing and presentation

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900077-3

7 January 2021

Mechanisms of MHC class I--restricted antigen processing

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900077-3

7 January 2021

Universally immunogenic T cell epitopes: promiscuous binding to human MHC class II and promiscuous recognition by T cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900077-3

7 January 2021

MHC class II-restricted antigen processing and presentation

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900077-3

7 January 2021

Viral strategies of immune evasion

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900077-3

7 January 2021

Synthesis and immunological characterization of 104-mer and 102-mer peptides corresponding to the N- and C-terminal regions of the Plasmodium falciparum CS protein

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900077-3

7 January 2021

Developing HPV virus-like particle vaccines to prevent cervical cancer: a progress report

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900077-3

7 January 2021

Tools of the trade in vaccine design.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900077-3

7 January 2021

A malaria T-cell epitope recognized in association with most mouse and human MHC class II molecules

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900077-3

7 January 2021

The host response to Leishmania infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900077-3

7 January 2021

Cytotoxic T cells recognize fragments of the influenza nucleoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900077-3

7 January 2021

Genes regulating MHC class I processing of antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900077-3

7 January 2021

Polio vaccines exonerated.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900077-3

7 January 2021

Generating MHC class I ligands from viral gene products

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900077-3

7 January 2021

Proteolysis and class I major histocompatibility complex antigen presentation

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900077-3

7 January 2021

Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900077-3

7 January 2021

The discovery of MHC restriction

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900077-3

7 January 2021

10.1016/S0161-5890(01)00077-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11741691%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

1 reference